AVH — AVITA Medical Income Statement
0.000.00%
Last trade - 00:00
- AU$391.45m
- AU$372.06m
- $50.14m
- 21
- 17
- 67
- 30
2020 June 30th | 2021 June 30th | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 14.3 | 29.2 | 34.4 | 50.1 |
Cost of Revenue | ||||
Gross Profit | 11.6 | 23.5 | 28.8 | 42.6 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 56.9 | 55.8 | 61.9 | 92.8 |
Operating Profit | -42.7 | -26.5 | -27.5 | -42.7 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -42 | -26.5 | -26.6 | -35.3 |
Provision for Income Taxes | ||||
Net Income After Taxes | -42 | -26.6 | -26.7 | -35.4 |
Net Income Before Extraordinary Items | ||||
Net Income | -42 | -26.6 | -26.7 | -35.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -42 | -26.6 | -26.7 | -35.4 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -2.06 | -1.17 | -1.06 | -1.39 |